【レポートの概要（一部）】
PART 01: Executive summary
Highlights
PART 02: Scope of the report
Market overview
Top-vendor offerings
PART 03: Market research methodology
Research methodology
Economic indicators
PART 04: Introduction
Key market highlights
PART 05: Antibacterial: overview
Introduction
Mechanism of action
General principles for the use of antibiotics
Clinical uses
Epidemiology
PART 06: Pipeline analysis
Zerbaxa
Surotomycin
MK-3415A
Amikacin Inhale
CARBAVANCE
Eravacycline
Plazomicin
Delafloxacin
Solithromycin
VivaGel
Arikayce
Cadazolid
Ozenoxacin
PART 07: Antimicrobial resistance
Sources of spread of resistant organisms
Initiatives to improve antibiotic innovation
PART 08: Legislation relating to antibiotic use in the US
PART 09: Market landscape
Market overview
Market size and forecast
Five forces analysis
PART 10: Market segmentation by chemical class
Beta-lactam
Macrolides
Aminoglycosides
Phenicols
Quinolones
Folate antagonists
Tetracyclines
Others
PART 11: Market segmentation by drug origin
Natural
Semisynthetic
Synthetic
PART 12: Market segmentation by mechanism of action
Bacteriostatic
Bactericidal
PART 13: Market segmentation by spectrum of activity
Broad spectrum antibiotics
Narrow spectrum antibiotics
PART 14: Geographical segmentation
Global antibacterial drugs market by geographical segmentation 2014-2019
Antibacterial drugs market in APAC
Antibacterial drugs market in EMEA
Antibacterial drugs market in Americas
PART 15: Market drivers
Special regulatory designations
Increase in prevalence of infections
Increase in awareness
Increase in aging population
PART 16: Impact of drivers
PART 17: Market challenges
Development of drug resistant strains
Patent expiries and generic penetration
Decreased investments in research activities
PART 18: Impact of drivers and challenges
PART 19: Market trends
Strategic alliances and M&A
Patient assistance programs
Increased funding on antibiotic research
PART 20: Vendor landscape
Competitive scenario
Market share analysis 2014
Other prominent vendors
PART 21: Key vendor analysis
Allergan
GSK
Merck
Pfizer
Sandoz
Teva Pharmaceuticals
PART 22: Appendix
List of abbreviation
PART 23: Explore Technavio
[List of Exhibits]
Exhibit 01: Product offerings
Exhibit 02: Mechanism of action of antibacterial drugs
Exhibit 03: General principles involved in the use of antibiotics
Exhibit 04: Estimated number of cases for nosocomial infections in US, 2011
Exhibit 05: Number of cases for Escherichia coli bacteremia in UK, 2012-2014
Exhibit 06: Global antibacterial drugs market: Pipeline portfolio
Exhibit 07: Causes of antimicrobial resistance
Exhibit 08: Sources of spread of resistant organisms
Exhibit 09: Estimated deaths per year caused by AMR in 2050
Exhibit 10: Initiatives improving antibiotic innovation
Exhibit 11: Legislation relating to antibiotic use in US
Exhibit 12: Global antibacterial drugs market 2014-2019 ($ billions)
Exhibit 13: Five forces analysis
Exhibit 14: Global antibacterial drugs market segmentation by chemical class
Exhibit 15: Cephalosporin segmentation by generation of drugs
Exhibit 16: Global antibacterial drugs market revenue segmentation by chemical class
Exhibit 17: Global antibacterial drugs market segmentation by drug origin
Exhibit 18: Global antibacterial drugs market segment by geography 2014
Exhibit 19: Antibacterial drugs market revenue by geography 2014-2019 ($ billions)
Exhibit 20: Antibacterial drugs market in APAC 2014-2019 ($ billions)
Exhibit 21: Antibacterial drugs market in EMEA 2014-2019 ($ billions)
Exhibit 22: Antibacterial drugs market in Americas 2014-2019 ($ billions)
Exhibit 23: Percentage share of antibacterial drugs market in Americas
Exhibit 24: Impact of drivers
Exhibit 25: Antibiotic-resistant strains according to the period of development of resistance
Exhibit 26: Antibacterial drug approvals by FDA and EMA
Exhibit 27: Impact of drivers and challenges
Exhibit 28: Allergan: YoY growth and revenue generated from net product sales of anti-infective 2011-2013 ($ millions)
Exhibit 29: Allergan: Key takeaways
Exhibit 30: GlaxoSmithKline: YoY growth and revenue generated from sales of Augmentin 2011-2014 ($ millions)
Exhibit 31: GlaxoSmithKline: Revenue generated from sales of Augmentin by region 2011-2014 ($ millions)
Exhibit 32: GlaxoSmithKline: YoY growth and revenue generated from sales of other antibacterials 2011-2013 ($ millions)
Exhibit 33: GlaxoSmithKline: Key takeaways
Exhibit 34: Merck: YoY growth and revenue generated from sales of Primaxin 2012-2014 ($ millions)
Exhibit 35: Merck: YoY growth and revenue generated from sales of Invanz 2012-2014 ($ millions)
Exhibit 36: Merck: Key takeaways
Exhibit 37: Pfizer: YoY growth and revenue generated from sales of Zyvox 2012-2014 ($ millions)
Exhibit 38: Pfizer: YoY growth and revenue generated from sales of Zithromax/Zmax 2012-2014 ($ millions)
Exhibit 39: Pfizer: YoY growth and revenue generated from sales of Unasyn 2012-2014 ($ millions)
Exhibit 40: Pfizer: YoY growth and revenue generated from sales of Zosyn/Tazocin 2012-2014 ($ millions)
Exhibit 41: Pfizer: YoY growth and revenue generated from sales of Sulperazon 2012-2014 ($ millions)
Exhibit 42: Pfizer: YoY growth and revenue generated from sales of Tygacil 2012-2014 ($ millions)
Exhibit 43: Pfizer: Key takeaways
Exhibit 44: Sandoz: Key takeaways
Exhibit 45: Teva Pharmaceuticals: Key takeaways
Exhibit 46: Allergan: Business segmentation by product revenue 2014
Exhibit 47: Allergan: Business segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 48: Allergan: Geographical segmentation by revenue 2014
Exhibit 49: GSK: Business segmentation by revenue 2014
Exhibit 50: GSK: Business segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 51: GSK: Geographical segmentation by revenue 2014
Exhibit 52: Merck: Business segmentation by revenue 2014
Exhibit 53: Merck: Business segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 54: Merck: Geographical segmentation by revenue 2014
Exhibit 55: Pfizer: Business segmentation by revenue 2014
Exhibit 56: Pfizer business segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 57: Pfizer: Geographical segmentation by revenue 2014
Exhibit 58: Sandoz: Business segmentation by revenue 2014
Exhibit 59: Teva Pharmaceuticals: Business segmentation by revenue 2014
Exhibit 60: Teva Pharmaceuticals: Business segmentation by revenue 2013 and 2014
Exhibit 61: Teva Pharmaceuticals: Geographical segmentation by revenue 2014
【レポート販売概要】
■ タイトル：抗菌薬の世界市場2015-2019■ 英文：Global Antibacterial Drugs Market 2015-2019
■ 発行日：2015年11月11日
■ 調査会社：Technavio
■ 商品コード：IRTNTR7883
■ 調査対象地域：グローバル
- ソフトスキルトレーニングの世界市場2016-2020About Soft Skills TrainingSoft skills can be broadly categorized under three segments: character, interpersonal skills, and critical and creative thinking. Soft skills play a crucial role in enabling individuals to communicate effectively, manage a team with good interpersonal skills, and solve problems. Therefore, apart from training students and employees in technical skills, organizations and e …
- 冷凍加工食品の世界市場予測2015-2025Chilled processed food is a relatively new sector of the global food market. Its current stage of development varies from country to country depending on many factors from social to economic. The industry is well developed in some countries. However, market players still have to overcome many obstacles in order to succeed in the chilled food sector in other regions of the market. North America and …
- スマートキッチンの世界市場：スマート冷蔵庫、スマート調理機器、スマート食器洗い機About Smart Kitchen The Internet of Things (IoT) is a network of physical or tangible objects or devices interconnected through multiple network technologies. These objects or devices can communicate with each other and with the external environment through the Internet. Smart kitchens are an integral part of smart homes. Smart kitchens provide a smart environment, which makes it easy for the user …
- 工業用インターネット（IIoT）の世界市場分析：コンポーネント別（ソリューション、サービス、プラットフォーム）、エンドユーザー別（製造、エネルギー･電力、石油・ガス、ヘルスケア、物流･輸送、農業）、地域別、セグメント予測、2014-2025The global industrial IoT market is expected to reach USD 933.62 billion by 2025, according to a new report by Grand View Research, Inc. The growing demand and adoption of cloud computing, coupled with the Scalability of IPv6-3.4X 10^38 IP address, are presumed to drive the market over the forecast period. Businesses, across the globe, are seeking new operating models to create a connected enterpr …
- カナダの呼吸装置市場Canada Respiratory Devices Market Outlook to 2021 Summary GlobalData’s new report, "Canada Respiratory Devices Market Outlook to 2021", provides key market data on the Canada Respiratory Devices market. The report provides value, in millions of US dollars, volume (in units) and average price data (in US dollars), within market segments - Humidifiers, Oxygen Concentrators, Ventilators, Nebulizers, …
- 耐摩耗コーティング剤の世界市場予測（～2024年）“Stringent regulations on VOC emission are expected to drive the global abrasion resistant coatings market.” The market size for abrasion resistant coatings is projected to grow from USD 8.0 billion in 2019 to USD 11.1 billion by 2024, at a CAGR of 6.5% during the forecast period. The major driving factors for the market are stringent EU and US regulations regarding VOC emission. The other major d …
- Richard Wolf GmbH：市場シェア分析Richard Wolf GmbH Market Share Analysis Summary GlobalData’s new report, “Richard Wolf GmbH Market Share Analysis” provides in-depth information on Richard Wolf GmbH’s market position in the different medical equipment markets it operates in. The report provides Richard Wolf GmbH market share information in two key market categories – Rigid Endoscopes and Flexible Endoscopes. The report also provi …
- 世界の海員市場（需要と供給分析）2014■Global Seafarers – supply and demand Here the report reviews the trends in seafarer (officer and ratings) in the past decade and forecasts seafarer requirements five years ahead. ■Key issues addressed: • How has the seafarer supply changed in relation to the wider changes in the size of the world merchant fleet in the past decade? • How many new buildings are likely to enter service by the end of …
- 熱伝導性材料の世界市場：ポリマー材料、フェイズチェンジ材、金属材料About TIM TIM is used to support heat sinks in removing heat from heat sources in various equipment. It is generally used in the form of a secondary thermally conducting material to replace the thermally insulating air between the two surfaces. Along with helping in the efficient transfer of heat, TIM also acts as an adhesive and strengthens the mechanical link between the surfaces. Polymer-based …
- Cimarex Energy Co.：石油・ガスバリューチェーン分析レポート2013Cimarex Energy Co. Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Cimarex Energy Co." Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Cimarex Energy Co.”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. The report examines t …
- 世界の動物診断・検査（医療機器）市場（2014-2018）About Veterinary Diagnostics Veterinary diagnostics include various tests, which are used to detect diseases in animals. Veterinarians, pet owners, livestock producers, and biomedical researchers are mainly availing these diagnostic services. Major diagnostic methods include molecular testing (Deoxyribonucleic Acid/Ribonucleic Acid testing), immunodiagnostics, clinical chemistry, and hematology. T …
- Addax Petroleum Corporation：石油・ガスバリューチェーン分析レポート2013Addax Petroleum Corporation Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Addax Petroleum Corporation" Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Addax Petroleum Corporation”. The report provides key information relating to oil and gas assets of the company along with its operations across the value c …
- 乳製品検査の世界市場予測（～2022年）：安全（病原体、混物、農薬）、品質、技術、製品“The dairy testing market is projected to grow at a CAGR of 7.4%.”The dairy testing market is projected to reach USD 5.90 billion by 2022 from USD 4.13 billion in 2017, at a CAGR of 7.4%. The market is driven by an increase in the outbreak of foodborne illnesses, globalization of dairy trade, and stringent safety and quality regulations for food. Lack of coordination between market stakeholders an …
- 世界のアルキルポリグルコシド市場2015The Global Alkyl Polyglucosides Industry Report 2015 is a professional and in-depth study on the current state of the Alkyl Polyglucosides industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Alkyl Polyglucosides market analysis is provided for the international markets including development trends, com …
- 瘢痕治療の世界市場2016-2020About Scar Treatment A scar is a patch of fibrous tissue (containing a protein called collagen) that is formed over a wound as a consequence of the body's natural healing process. Scars are classified into keloid scars, contracture scars, hypertrophic scars, and atrophic scars based on the composition of collagen and appearance. Many non-invasive methods including chemical and physical treatment a …
